The KAMRA Inlay is a breakthrough in correcting the need for reading glasses, and is now our primary treatment for anyone aged 45 upwards. You can read an article from yesterday’s London Evening Standard all about KAMRA. It features Karen who had the Keyhole KAMRA version, where no LASIK-type flap is created, and the inlay is simply inserted into a tiny pocket through a keyhole entrance. Unlike LASIK, there is no significant dry eye and the patient could even rub their eyes afterwards without risk of dislodging anything.

You can see the full article here: www.thisislondon.co.uk/standard/article-24014966-london-clinic-develops-10-minute-operation-to-freeze-failing-eyesight.do

You can learn more about KAMRA and presbyopia here at KAMRAvision.com

A new lens to help reading vision has received approval from the American Food & Drug Administration (FDA), according to manufacturers Bausch & Lomb, based at Rochester in New York state.

These lenses are inserted inside the eye during a procedure very similar to that used for cataract surgery. The natural lens is removed and replaced with an artificial intraocular lens (IOL). The traditional IOL has a fixed focus and is unable to replicate the natural flexibility of the young human lens that allows us to zoom in on near objects to have clear close vision, e.g. reading a newspaper print.

Accommodating lenses are designed to mimic the natural zoom ability to not only provide clear distance vision but also to restore good near vision. This loss of near vision with age is called ‘presbyopia‘ and affects 20 million people in the UK alone.

The Crystalens HD is designed for enhanced depth of focus and features something called “proprietary optical focus,” B&L stated in a press release. This optical ability is claimed to be capable of improving near vision without reducing distance or intermediate vision. In the research study from B&L, 125 eyes were implanted with the new Crystalens HD. These patients had a visually significant cataract (usually age related clouding of the lens inside the eye), less than 1 D of corneal astigmatism, and the potential for best corrected visual acuity of 20/25 or better in both eyes. Of this study population, four out of five patients (80%) had vision of J2 (equivalent to small ingredients lists on food packets) or better at 4 months. B&L said it plans to begin sending out the Crystalens HD in early July.

TECHNOLOGY that has become available over past two years means that reading vision problems can now be very effectively addressed through laser eye treatment. Although at present only a few clinics specialise in this area, it is the fasting growing section of the laser vision arena.

FOCUS Laser Vision specialises in the correction of loss of reading vision, either through advanced LASIK laser eye surgery or through the use of lenses inside the eye (IOLs)

Several approaches to LASIK are showing promise in the treatment of reading vision problems (presbyopia) for patients with otherwise normal distance vision, or long or short sight, according to studies presented at the 12th Winter Refractive Meeting of the ESCRS.

In research presented by Kenneth A Greenberg MD, all patients achieved good distance vision of 20/25 or better and were able to read telephone directory sized print, 12 months after undergoing customised LASIK treatments. The multicentre study involved 28 presbyopic long-sighted patients with an average age of 56 years.

Leeds-based laser eye surgery company Ultralase has increased its network of clinics by acquiring The Cambridge Eye Laser Clinic for an undeclared sum. The purchase is the company’s second since it was bought by 3i in February for £174 million, and follows the acquisition of Belfast’s Allclear clinic in April.

The Cambridge Eye Laser Clinic was created in 2002 by eye surgeon and clinical director Chris Stephenson as part of the Allclear Group of clinics. Stephenson bought out the clinic from the group in 2006.

The Cambridge centre add to Ultralase’s 23 UK clinics as part of the group’s ambitious expansion plans. Ultralase recently opened a new consulting room in Sheffield, with plans to open 3 more in 2008.

WaveLight AG, based in Erlangen, Germany [who make the excellent Allegretto eye laser] increased its sales for the first nine months of 2007/8 accounting year by 31% to €65 million. The previous year’s turnover was €49.5 million for the same period.

The company’s market position in the U.S. has also expanded. In the worldwide sales-strong US market, which has been of great importance for WaveLight for the refractive surgery area, the company exceeded the turnover of the comparable period in the previous year by 66%.

WaveLight make the Allegretto Eye-Q 400 Hz excimer system for laser eye surgery. You can see the FDA results for the WaveLight laser versus other systems here.

You can still read Rick’s story about his treatment with me, online at the Daily Mail’s website. Rick talks about the whole process in a very interesting article from Rachel Kaufman.

Follow the link below to read the full article.

www.dailymail.co.uk/health/article-404859/New-laser-surgery-cured-long-short-sight.html

Advanced Medical Optics Inc. in Santa Ana, announced on Wednesday that the Food and Drug Administration (FDA) has approved a new laser for use in laser eye correction. The iFS femtosecond laser is set to be at the centre of AMO’s iLasik products for laser vision surgery. The laser has an increased speed of 150kHz, up from the existing 60kHz.

However, competitor Ziemer from Switzerland recently launched its own femtosecond laser offering more than 1000kHz speed, integral to its Z-LASIK offering. Click here for a discussion blog post comparing iLASIK and Z-LASIK.

AMO has pushed into laser vision correction, including its $800 million buy of Irvine, California-based IntraLase Corporation last year. The iFS laser uses technology from IntraLase. The femtosecond laser is used to create a corneal flap which is the first step in laser vision surgery. Advanced Medical’s lasers have been gaining market share over traditional metal blades. The laser is due to be shipped to U.S. laser eye surgeons in the third quarter, according to Advanced Medical Optics.

Tags: Z-LASIK, iLASIK, AMO, FDA, femtosecond, eye, laser, surgery

British private equity firm 3i has agreed to buy Ultralase from Spain’s cosmetic surgery group Dermoestetica. The Spanish group said the price was 174.5 millon pounds (238 million euros, 348 million dollars). There is an exclusivity period on this deal until January 30 2008. 3i made an approach to Dermoestetica just recently in November 2007.Dermoestetica has 90 clinics across Europe and is a leading cosmetic surgery provider. It bought the British firm Ultralase in 2005 for 29 million pounds in 2005. With a bump in price of £145 million in 2 years, or a mere £200,000 per day, the Spanish group will be all smiles, and no glasses!